Xu X - Search Results

1

Role of PLGA Variability in Controlled Drug Release from Dexamethasone Intravitreal Implants.

Costello MA, Liu J, Kuehster L, Wang Y, Qin B, Xu X, Li Q, Smith WC, Lynd NA, Zhang F. Costello MA, et al. Among authors: xu x. Mol Pharm. 2023 Dec 4;20(12):6330-6344. doi: 10.1021/acs.molpharmaceut.3c00742. Epub 2023 Nov 13. Mol Pharm. 2023. PMID: 37955890

2

Quality by design approach for understanding the critical quality attributes of cyclosporine ophthalmic emulsion.

Rahman Z, Xu X, Katragadda U, Krishnaiah YS, Yu L, Khan MA. Rahman Z, et al. Among authors: xu x. Mol Pharm. 2014 Mar 3;11(3):787-99. doi: 10.1021/mp400484g. Epub 2014 Jan 24. Mol Pharm. 2014. PMID: 24423028

3

Development of performance matrix for generic product equivalence of acyclovir topical creams.

Krishnaiah YS, Xu X, Rahman Z, Yang Y, Katragadda U, Lionberger R, Peters JR, Uhl K, Khan MA. Krishnaiah YS, et al. Among authors: xu x. Int J Pharm. 2014 Nov 20;475(1-2):110-22. doi: 10.1016/j.ijpharm.2014.07.034. Epub 2014 Jul 30. Int J Pharm. 2014. PMID: 25089511

4

Kinetics of drug release from ointments: Role of transient-boundary layer.

Xu X, Al-Ghabeish M, Krishnaiah YS, Rahman Z, Khan MA. Xu X, et al. Int J Pharm. 2015 Oct 15;494(1):31-9. doi: 10.1016/j.ijpharm.2015.07.077. Epub 2015 Aug 1. Int J Pharm. 2015. PMID: 26241753

5

Risk based in vitro performance assessment of extended release abuse deterrent formulations.

Xu X, Gupta A, Al-Ghabeish M, Calderon SN, Khan MA. Xu X, et al. Int J Pharm. 2016 Mar 16;500(1-2):255-67. doi: 10.1016/j.ijpharm.2016.01.031. Epub 2016 Jan 16. Int J Pharm. 2016. PMID: 26784976 Free PMC article.

6

Asymmetric flow field flow fractionation for the characterization of globule size distribution in complex formulations: A cyclosporine ophthalmic emulsion case.

Qu H, Wang J, Wu Y, Zheng J, Krishnaiah YSR, Absar M, Choi S, Ashraf M, Cruz CN, Xu X. Qu H, et al. Among authors: xu x. Int J Pharm. 2018 Mar 1;538(1-2):215-222. doi: 10.1016/j.ijpharm.2018.01.012. Epub 2018 Jan 16. Int J Pharm. 2018. PMID: 29341918

7

Formulation characteristics and in vitro release testing of cyclosporine ophthalmic ointments.

Dong Y, Qu H, Pavurala N, Wang J, Sekar V, Martinez MN, Fahmy R, Ashraf M, Cruz CN, Xu X. Dong Y, et al. Among authors: xu x. Int J Pharm. 2018 Jun 10;544(1):254-264. doi: 10.1016/j.ijpharm.2018.04.042. Epub 2018 Apr 21. Int J Pharm. 2018. PMID: 29684560

8

Analytical considerations for measuring the globule size distribution of cyclosporine ophthalmic emulsions.

Petrochenko PE, Pavurala N, Wu Y, Yee Wong S, Parhiz H, Chen K, Patil SM, Qu H, Buoniconti P, Muhammad A, Choi S, Kozak D, Ashraf M, Cruz CN, Zheng J, Xu X. Petrochenko PE, et al. Among authors: xu x. Int J Pharm. 2018 Oct 25;550(1-2):229-239. doi: 10.1016/j.ijpharm.2018.08.030. Epub 2018 Aug 17. Int J Pharm. 2018. PMID: 30125649

9

Probing the mechanism of bupivacaine drug release from multivesicular liposomes.

Manna S, Wu Y, Wang Y, Koo B, Chen L, Petrochenko P, Dong Y, Choi S, Kozak D, Oktem B, Xu X, Zheng J. Manna S, et al. Among authors: xu x. J Control Release. 2019 Jan 28;294:279-287. doi: 10.1016/j.jconrel.2018.12.029. Epub 2018 Dec 18. J Control Release. 2019. PMID: 30576748

10

An in vitro approach for evaluating the oral abuse deterrence of solid oral extended-release opioids with properties intended to deter abuse via chewing.

Externbrink A, Sharan S, Sun D, Jiang W, Keire D, Xu X. Externbrink A, et al. Among authors: xu x. Int J Pharm. 2019 Apr 20;561:305-313. doi: 10.1016/j.ijpharm.2019.03.017. Epub 2019 Mar 9. Int J Pharm. 2019. PMID: 30862508

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

57,396 results

Search Page

Filters